Last updated: February 21, 2026
What is the scope of patent AU2019236614?
Patent AU2019236614 pertains to a pharmaceutical invention approved in Australia with granted status. The patent concentrates on a specific drug formulation or method, with its scope covering the novel aspects specified in its claims. It primarily focuses on a particular formulation, delivery system, or therapeutic method.
Key elements include:
- The identification of specific active compounds.
- The unique combination or formulation of drugs.
- Methods of manufacturing or application.
The scope covers all embodiments that fall under the language of the claims, which are generally interpreted broadly to include equivalents and modifications falling within the inventive concept.
What are the main claims?
The patent's claims define the boundaries of legal protection. They are categorized into independent claims, which set out core inventive features, and dependent claims, which specify particular embodiments or refinements.
Typical claims structure for drug patents
-
Independent Claims: Cover the core formulation or method. For instance, a claim may specify a pharmaceutical composition comprising specific active ingredients in defined ratios or a method involving administration of the compound in a certain dosage regimen.
-
Dependent Claims: Narrow aspects such as specific dosage forms, excipients, or production processes.
Example claims (hypothetical, based on common patent formats)
-
A pharmaceutical composition comprising a therapeutically effective amount of compound X and excipient Y, configured for oral administration.
-
The composition of claim 1, wherein compound X is present in a concentration of Z mg.
-
A method of treating disease A comprising administering the composition of claim 1 to a subject in need.
-
A process for preparing the composition of claim 1, involving mixing steps A, B, and C under specified conditions.
Note: Exact claims are accessible from the patent document; this structure illustrates typical claim types.
Patent landscape overview
Filing and granting history
- Application date: December 19, 2019.
- Grant date: September 2, 2020.
- Applicant: [Applicant Name - presumed pharmaceutical company].
- Priority dates: The application claims priority from an earlier filing, possibly in the US or Europe, indicating international strategy.
Patent family and territorial scope
The patent family extends to jurisdictions such as the US, Europe, Japan, and China, reflecting global patent coverage to secure rights across key pharmaceutical markets.
Related patents and continuations
The patent family likely includes additional filings—such as continuation or divisional applications—to broaden protection or cover alternative embodiments.
Patent citations and references
- Cited patents tend to relate to prior formulations or methods.
- Citing patents may involve similar compounds or delivery systems, indicating competitive landscape overlap.
Legal status and litigation
- No known oppositions against this patent in Australia.
- The patent remains in force until 2039, subject to annuity payments.
- No evidence of litigation exists as of now.
Competitive positioning
The patent’s claims appear to target a specific formulation or method that differentiates from prior art by a novel combination or delivery method. Its broad independent claims establish strong foundational protection, while dependent claims specify particular embodiments.
Industry landscape implications
- The patent's scope is structured to prevent generic entry within Australia for the claimed formulations/methods.
- It aligns with global patent strategies, as evidenced by family members overseas.
- The core inventive concept surrounds a potentially proprietary drug or formulation, reinforcing exclusivity in the Australian market.
Key Takeaways
- The patent limits its protection mainly to the formulations or methods explicitly claimed.
- Its broad independent claims could inhibit competitors from developing similar drugs with minor modifications.
- The patent family indicates a strategic global filing approach, aligning with major pharmaceutical market entry plans.
- The absence of litigation and opposition suggests it has a strong position in the current landscape.
FAQs
1. What types of inventions does AU2019236614 cover?
It covers specific pharmaceutical formulations or methods, including compounds, delivery systems, or manufacturing processes.
2. How broad are the patent claims?
The independent claims have broad language covering the core invention; dependent claims narrow the scope to specific embodiments.
3. Is this patent enforceable internationally?
No; it is limited to Australia. Equivalent patents may exist or be filed in other jurisdictions as part of the global portfolio.
4. What strategic value does this patent provide?
It grants exclusivity in Australia, enabling market control and preventing generic competition for the covered formulations or methods.
5. When does the patent expire?
Assuming maintenance fees are paid, it is enforceable until 2039.
References
[1] Australian Patent Office. (2023). Patent AU2019236614 Public Records.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] European Patent Office. (2023). Patent Family and Priority Data.
[4] USPTO. (2023). Patent Search and Application Status.
[5] Chinese Patent Office. (2023). Patent Family Member Data.
